Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| ANI PHARMACEUTICALS | 10 | 5 | +8,73 % | ||
| AMNEAL PHARMACEUTICALS | 10 | - | 0,00 % | ||
| MODERNA | 9 | 16 | -0,41 % | ||
| CG ONCOLOGY | 7 | - | +4,78 % | ||
| PROTHENA | 6 | 1 | 0,00 % | ||
| BEONE MEDICINES LTD ADR | 5 | 10 | +0,75 % | ||
| NOVAVAX | 5 | 7 | -0,97 % | ||
| PERSONALIS | 5 | - | -2,15 % | ||
| CARIS LIFE SCIENCES | 5 | - | +5,56 % | ||
| REGENERON PHARMACEUTICALS | 4 | 22 | 0,00 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02:18 | Josh Gottheimer makes key trades in Gilead Sciences and Intercontinental Exchange | 2 | Investing.com | ||
| 00:00 | Ascendis Pharma: FDA Approves Once-Weekly YUVIWEL (navepegritide) for Children with Achondroplasia Aged 2 Years and Older | 2 | GlobeNewswire (USA) | ||
| Fr | Harrow Health Q4 2025 Earnings Preview | 3 | Seeking Alpha | ||
| Fr | Disc Medicine undergoes restructuring plan; slashes 20% of workforce | 4 | Seeking Alpha | ||
| Fr | Tectonic Therapeutic, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 4 | SEC Filings | ||
| Fr | Analyst Bullish on Cogent (COGT) Amid Expected Drug Approval | 2 | Insider Monkey | ||
| Fr | Citi, Stifel Bullish on Olema (OLMA) Despite COO Departure | 3 | Insider Monkey | ||
| Fr | P/E Ratio Insights for Gilead Sciences | 4 | Benzinga.com | ||
| Fr | What Analysts Are Saying About CG Oncology Stock | 1 | Benzinga.com | ||
| Fr | Adaptive Biotechnologies Corp - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| Fr | PROTHENA CORP PUBLIC LTD CO - 8-K, Current Report | 1 | SEC Filings | ||
| Fr | Prothena authorizes $100 million share buyback program | 1 | Investing.com | ||
| Fr | Novocure to Participate in 2026 Leerink Global Healthcare Conference | 182 | Business Wire | Novocure (NASDAQ: NVCR) announced today that management will participate in the Leerink Global Healthcare Conference on Tuesday, March 10, 2026. Frank Leonard, Chief Executive Officer, and Christoph... ► Artikel lesen | |
| Fr | Prothena kündigt Aktienrückkaufprogramm über 100 Mio. US-Dollar an | 1 | Investing.com Deutsch | ||
| Fr | Prothena authorizes up to $100 million share repurchase plan | 4 | Seeking Alpha | ||
| Fr | Aardvark Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| Fr | Amneal Pharmaceuticals, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| Fr | Prothena Corporation plc: Prothena Announces up to $100 Million Share Repurchase Plan | 203 | Business Wire | Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced... ► Artikel lesen | |
| Fr | Aardvark Therapeutics, Inc.: Aardvark Therapeutics Announces Voluntary Pause of Phase 3 HERO Trial in Prader-Willi Syndrome | 1 | GlobeNewswire (USA) | ||
| Fr | PROTHENA CORP PUBLIC LTD CO - 10-K, Annual Report | 2 | SEC Filings |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.